AstraZeneca Pharma India Limited (ASTRAZEN.NS)

INR 6482.05

(-0.0%)

Annual Balance Sheets

(In INR)
Breakdown 2024 2023 2022 2021 2020 2019
Total Assets 10.78 Billion 9.84 Billion 8.56 Billion 7.74 Billion 7.06 Billion 5.61 Billion
Total Current Assets 9.32 Billion 8.35 Billion 7.05 Billion 6.18 Billion 5.42 Billion 4.04 Billion
Cash And Short Term Investments 5.05 Billion 5.11 Billion 4.48 Billion 3.52 Billion 2.52 Billion 1.73 Billion
Cash and Cash Equivalents 5.05 Billion 5 Billion 4.48 Billion 3.52 Billion 835 Million 1.73 Billion
Short Term Investments 181.5 Million 107.17 Million 123.1 Million 56.56 Million 1.69 Billion -
Net Receivables 1.53 Billion 1.07 Billion 982.85 Million 912.16 Million 956 Million 912.1 Million
Inventory 2.27 Billion 1.9 Billion 1.4 Billion 1.59 Billion 1.65 Billion 1.18 Billion
Other Current Assets 457.29 Million 266.17 Million 187.44 Million 154.03 Million 290.7 Million 221.7 Million
Total Non-Current Assets 1.45 Billion 1.49 Billion 1.5 Billion 1.55 Billion 1.64 Billion 1.57 Billion
Net PPE 648.42 Million 701.94 Million 766.9 Million 849.8 Million 960.1 Million 835.7 Million
Good Will And Intangible Assets 21.1 Million 76.21 Million - -43.3 Million -39 Million -28.6 Million
Good Will 5000.00 - - - - -
Intangible Assets 21.1 Million - - - - -
Long-Term Investments 27.41 Million -76.21 Million -93.8 Million 43.3 Million 39 Million 28.6 Million
Tax Assets 212.49 Million 205.67 Million 163 Million 145.3 Million 146.4 Million 233.6 Million
Other Non Current Assets 543.79 Million 586.34 Million 672.8 Million 564.4 Million 533.9 Million 501.5 Million
Other Assets 1.00 - - - - -
Total Liabilities 3.66 Billion 3.96 Billion 3.45 Billion 3.18 Billion 3.41 Billion 2.61 Billion
Total Current Liabilities 3.57 Billion 3.83 Billion 3.32 Billion 3.03 Billion 3.27 Billion 2.58 Billion
Account Payables 1.96 Billion 2.27 Billion 1.88 Billion 1.78 Billion 2.09 Billion 1.68 Billion
Tax Payables 66.61 Million 24.22 Million 49.4 Million 56.3 Million 21 Million 18.3 Million
Short Term Debt 18.14 Million 35.22 Million 36.1 Million 35.1 Million 25.4 Million -
Deferred Revenue 66.61 Million 401.7 Million 306.9 Million 1.07 Billion 1.02 Billion -
Other Current Liabilities 1.52 Billion 1.12 Billion 1.1 Billion 136.5 Million 123.4 Million 907.8 Million
Total Non Current Liabilities 89.93 Million 122.55 Million 125.2 Million 150.4 Million 146.8 Million 20.2 Million
Long-Term Debt 27.83 Million 36.91 Million 50.2 Million 86.3 Million 93 Million -
Deferred Revenue Non Current -10.6 Million -15.3 Million -18.7 Million -27.8 Million -28.3 Million -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 62.09 Million 85.64 Million 75 Million 64.1 Million 53.8 Million 9.6 Million
Other Liabilities 1.00 - - - - -
Total Equity 7.11 Billion 5.88 Billion 5.11 Billion 4.56 Billion 3.64 Billion 3 Billion
Stock Holders Equity 7.11 Billion 5.88 Billion 5.11 Billion 4.56 Billion 3.64 Billion 3 Billion
Common Stock 50 Million 50 Million 50 Million 50 Million 50 Million 50 Million
Retained Earnings 5.78 Billion 4.55 Billion 3.78 Billion 3.24 Billion 2.32 Billion 1.68 Billion
Accumulated other comprehensive income 564.19 Million 557 Million 550.8 Million 547.19 Million 1.27 Billion -472.4 Million
Common Stock Equity 7.11 Billion 5.88 Billion 5.11 Billion 4.56 Billion 3.64 Billion 3 Billion
Capital Lease Obligation 27.83 Million 72.13 Million 86.3 Million 121.4 Million 118.4 Million -
Total Investments 27.41 Million 30.95 Million 29.3 Million 56.56 Million 1.69 Billion 28.6 Million
Total Debt 45.98 Million 72.13 Million 86.3 Million 121.4 Million 118.4 Million -
Net Debt -5.01 Billion -4.93 Billion -4.39 Billion -3.4 Billion -716.6 Million -1.73 Billion

Balance Sheet Charts